FDA STAFF MANUAL GUIDES, VOLUME II - DELEGATIONS OF AUTHORITY
ADMINISTRATIVE - PERSONNEL
AUTHORITY TO GRANT LEAVE AND EXCUSE ABSENCES
Effective Date: 11/12/2004
1. AUTHORITY DELEGATED.
A. To grant leave to or to excuse the absence of the entire FDA workforce.
B. To approve use of advance sick leave up to 30 days.
C. To approve use of advance annual leave for the current leave year.
D. To approve requests for leave without pay that singly, or in aggregate, exceed 30 calendar days in any calendar year.
E. To order involuntary leave after consultation with servicing Employee and Labor Relations Specialist. (Also referred to as enforced leave. When employee is placed in a non-pay status or required to involuntarily use annual or sick leave.)
F. To approve use of sick leave.
G. To approve use of annual leave.
H. To approve requests for leave without pay that singly or in aggregate total 30 calendar days or less in any calendar year.
I. To grant court leave and military leave.
J. To excuse absence in situations where leave is ordinarily not charged.
2. TO WHOM DELEGATED.
A. The authority listed in paragraph 1.A. remains with the Commissioner and the Associate Commissioner for Management, and is delegated to the Director, Office of Management Programs.
B. The authorities listed in paragraphs 1.B. through 1.E. are delegated to the second line supervisor.
C. The authorities listed in paragraphs 1.F. through 1.J. are delegated to the first line supervisor.
All previous delegations of authority inconsistent with the provisions of this delegation are superseded.
3. REDELEGATION AND CERTIFICATION.
The authorities in 1.B. through 1.E. may be redelegated to a position not lower than that of first level supervisor. Any redelegation must be in writing and specify the nature and extent of the authority redelegated. Delegates must be certified as knowledgeable about the legal, regulatory, and policy requirements regarding the subject authority. A copy of the redelegation of this authority must be furnished to the Director, Office Management Programs (HFA-400) and to the FDA Delegations Officer (HFA-340). Delegates are subject to compliance audits.
4. EFFECTIVE DATE.
This delegation was signed by Jeffrey M. Weber, Associate Commissioner for Management, on November 12, 2004.